V. Vijaya Padma
- Molecular Biology top 5%
- Oncology top 2%
- Organic Chemistry top 2%
- Rehabilitation top 0.2%
- Biomaterials top 1%
- Co-authors
- Elango SanthiniP. PoornimaChih‐Yang HuangRathinasamy BaskaranKaruppannan NatarajanP. KalaivaniR. PrabhakaranLohanathan Bharathi Priya
- Topics
- Metal complexes synthesis and properties (13 papers)Adipose Tissue and Metabolism (10 papers)Cardiac Ischemia and Reperfusion (9 papers)
- Cited by
- RehabilitationBiomaterialsOncology
- Partner nations
- IndiaTaiwanUnited States
In The Last Decade
V. Vijaya Padma
102 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Molecular Biology 1.4k
- Oncology 1.1k
- Organic Chemistry 883
- Rehabilitation 881
- Biomaterials 717
Countries citing papers authored by V. Vijaya Padma
This map shows the geographic impact of V. Vijaya Padma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Vijaya Padma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Vijaya Padma more than expected).
Fields of papers citing papers by V. Vijaya Padma
This network shows the impact of papers produced by V. Vijaya Padma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Vijaya Padma. The network helps show where V. Vijaya Padma may publish in the future.
Co-authorship network of co-authors of V. Vijaya Padma
This figure shows the co-authorship network connecting the top 25 collaborators of V. Vijaya Padma. A scholar is included among the top collaborators of V. Vijaya Padma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Vijaya Padma. V. Vijaya Padma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 27 | |
| 5 | Association Between Prolonged QTc Interval and Microalbuminuria in Patients of Type II Diabetes Mellitus | 0 |
| 6 | 27 | |
| 7 | 18 | |
| 8 | 11 | |
| 9 | 34 | |
| 10 | 8 | |
| 11 | 54 | |
| 12 | 17 | |
| 13 | 2 | |
| 14 | 42 | |
| 15 | 20 | |
| 16 | 10 | |
| 17 | 48 | |
| 18 | 75 | |
| 19 | 82 | |
| 20 | 44 |
About V. Vijaya Padma
V. Vijaya Padma is a scholar working on Complementary and alternative medicine, Toxicology and Pharmacology, having authored 104 papers that have together received 4.7k indexed citations. Recurring topics across this work include Metal complexes synthesis and properties (13 papers), Adipose Tissue and Metabolism (10 papers) and Cardiac Ischemia and Reperfusion (9 papers). The work is most often cited by research in Rehabilitation (881 citations), Biomaterials (717 citations) and Oncology (1.1k citations). V. Vijaya Padma has collaborated with scholars based in India, Taiwan and United States. Frequent co-authors include Elango Santhini, P. Poornima, Chih‐Yang Huang, Rathinasamy Baskaran, Karuppannan Natarajan, P. Kalaivani, R. Prabhakaran, Lohanathan Bharathi Priya, F. Dallemer and Wei‐Wen Kuo. Their work appears in journals such as PLoS ONE, Scientific Reports and Free Radical Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.